| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/1998 | EP0837880A2 Enamel matrix related polypeptide |
| 04/29/1998 | EP0837875A2 Inhibitors of farnesyl-protein transferase |
| 04/29/1998 | EP0837874A2 Neuroactive steroids of the androstane and pregnane series |
| 04/29/1998 | EP0837864A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 04/29/1998 | EP0837863A1 Disodium alendronate formulations |
| 04/29/1998 | EP0837861A1 New pyrido-thiopyranoindazoles with antitumor activity |
| 04/29/1998 | EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES |
| 04/29/1998 | EP0837859A1 Tetrahydrofuran antifungals |
| 04/29/1998 | EP0837858A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/29/1998 | EP0837855A1 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas |
| 04/29/1998 | EP0837854A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 04/29/1998 | EP0837848A1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 04/29/1998 | EP0837845A1 Herpes ribonucleotide reductase inhibitors |
| 04/29/1998 | EP0837839A2 9-substituted porphycenes |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0837695A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep |
| 04/29/1998 | EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue |
| 04/29/1998 | EP0837686A2 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 04/29/1998 | EP0837685A2 Use of indigestible oligosaccharides to prevent and treat diarrhea |
| 04/29/1998 | EP0837684A1 Pharmaceutical compositions containing a diclofenac salt and thiocolchicoside |
| 04/29/1998 | EP0837683A1 Preparation and use of sulfated oligosaccharides |
| 04/29/1998 | EP0837682A1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts |
| 04/29/1998 | EP0837681A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 04/29/1998 | EP0837680A1 Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system |
| 04/29/1998 | EP0837678A1 N,n-dimethyl-8,8-dipropyl-2-azaspiro 4,5]decane-2-propanamine dimaleate |
| 04/29/1998 | EP0837676A1 Use of pyruvate for retarding neutrophil infiltration and morphologic loss in ischemic bowel |
| 04/29/1998 | EP0837673A2 Polymeric lamellar substrate particles for drug delivery |
| 04/29/1998 | EP0837630A1 Prodrugs of pharmaceuticals with improved bioavailability |
| 04/29/1998 | EP0801566A4 4,4-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 04/29/1998 | EP0794773A4 1,4,4-(trisubstituted)cyclohexane monomers and related compounds |
| 04/29/1998 | EP0734373B1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them |
| 04/29/1998 | EP0722448A4 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/29/1998 | EP0720597B1 Triaryl-ethylene derivatives for use in therapy |
| 04/29/1998 | EP0664704B1 Use of dopamine agonists to activate gamma-interferon production |
| 04/29/1998 | EP0594857B1 Methanediphosphonic acid derivative, production thereof and medicinal use thereof |
| 04/29/1998 | EP0557348B1 Avermectins and milbemycins to treat parasitic in dogs |
| 04/29/1998 | EP0537191B1 Treatment of organ transplantation rejection |
| 04/29/1998 | EP0536269B1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180359A Ascomycins |
| 04/29/1998 | CN1180358A Bridged indoles as matrix metalloprotease inhibitors |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1180356A Process for synthesis of nucleoside analogue |
| 04/29/1998 | CN1180354A Heterocyclic spiro derivatives |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1180351A Benzothiazine dioxides as endothelin antagonists |
| 04/29/1998 | CN1180348A Pyrrolidinyl hydroxamic acid compounds and their production process |
| 04/29/1998 | CN1180311A Use of 'alpha' 1L agonists in treatment of incontinence |
| 04/29/1998 | CN1180309A Package holding procaterol hydrochloride aqueous solution formulation, and procaterol hydrochloride aqueous solution formulation |
| 04/29/1998 | CN1180065A Antianaphylaxis, anti-asthma and anti-inflammatory new medicine |
| 04/29/1998 | CN1179973A Method for preparing fagopyrum cymosum preparation |
| 04/29/1998 | CN1179944A Use of strontium salts for production of pharmaceutical compositions intended for treatment of arthrosis |
| 04/29/1998 | CN1179942A Long-acting subcutaneous contraceptive implanting agent containing pregnadienone |
| 04/29/1998 | CN1179941A Suppository for curing prostatitis |
| 04/29/1998 | CN1038181C One-step process for producing polyvinyl pyrrolidone-iodine aerosol |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744623 Terpene-quinones with antitumour activity |
| 04/28/1998 | US5744621 Cis-epoxide compounds |
| 04/28/1998 | US5744607 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 04/28/1998 | US5744601 Cyclization of aminomalonic ester with guanidine; chlorination; reacting with aqueous solution of carboxylic acid |
| 04/28/1998 | US5744598 Imines of porphyrins, of porphyrin derivatives, and of related compounds, and pharmaceutical compositions containing such imines |
| 04/28/1998 | US5744596 Antivirus agent |
| 04/28/1998 | US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
| 04/28/1998 | US5744592 Improving the bioavailability and absorption of a drug through the digestive tract by covalently bonding the drug and a 1-o-or-s-alkyl-sn-glycero-3-phosphate |
| 04/28/1998 | US5744501 Treating late luteal phase dysphoric disorder (pms) by administering a serotonin reuptake blocker |
| 04/28/1998 | US5744500 Administering to treat brain ischemia or stroke |
| 04/28/1998 | US5744499 Apoptosis-modulating factors influencing the intracellular concentration of methional/malondialdehyde |
| 04/28/1998 | US5744498 Inhibiting growth and spread of malignancy and retarding DNA breaks |
| 04/28/1998 | US5744497 Trinuclear cationic platinum complexes having antitumor activity and pharmaceutical compositions containing them |
| 04/28/1998 | US5744495 Immunomodulatory agents |
| 04/28/1998 | US5744494 Veterinary, human use |
| 04/28/1998 | US5744493 3-amidopyrazole derivatives and pharmaceutical compositions containing them |
| 04/28/1998 | US5744492 Method for inhibiting angiogenesis |
| 04/28/1998 | US5744491 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 04/28/1998 | US5744489 Administering certain 1,2,5-thiadiazole and 1,2,5-oxadiazole compounds |
| 04/28/1998 | US5744488 Indole derivatives thromboxane A2 antagonists |
| 04/28/1998 | US5744485 Carbamates and ureas as modifiers of multi-drug resistance |
| 04/28/1998 | US5744484 Lubeluzole intravenous solutions |
| 04/28/1998 | US5744483 Neuroprotective compounds |
| 04/28/1998 | US5744481 β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/28/1998 | US5744480 Antiinflammatory agents, nervous system disorders |
| 04/28/1998 | US5744478 Thiazolo 3,2-a! quinoline and thiazolo 3,2-a! naphthyridine derivatives |
| 04/28/1998 | US5744477 Administering an inhibitor in combination with restricting the caloric intake of the subject |
| 04/28/1998 | US5744476 Dopamine D1 agonists for the treatment of dementia |
| 04/28/1998 | US5744474 Administering venlafaxine or duloxetine; treating stress, urge and/or nocturnal urinary incontinence |
| 04/28/1998 | US5744471 Pyridazion quinoline compounds |
| 04/28/1998 | US5744470 Method for treating insomnia |
| 04/28/1998 | US5744469 Administering 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno(2,3b)(1,5)benzo diazepine or a salt thereof to a patient |
| 04/28/1998 | US5744468 Treatment of glaucoma |
| 04/28/1998 | US5744467 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 04/28/1998 | US5744466 Therapeutic heterocyclic compounds |
| 04/28/1998 | US5744465 Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems |
| 04/28/1998 | US5744464 Dysmennhorea |
| 04/28/1998 | US5744463 Administering natural progesterone |
| 04/28/1998 | US5744461 Viricides |
| 04/28/1998 | US5744458 Kappa agonist compounds and pharmaceutical formulations thereof |
| 04/28/1998 | US5744457 Compositions and methods for inhibiting thrombogenesis |
| 04/28/1998 | US5744455 Reduction of anthracycline-induced cardiotoxicity |
| 04/28/1998 | US5744454 Anthracycline derivatives |
| 04/28/1998 | US5744453 Polyamine conjugates for treatment of infection |